<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: The purpose of this study is to compare physical activity (PA) levels between <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> survivors and those without <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> diagnosis (non-<z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> participants) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Using data from the 2009 Behavioral Risk Factor Surveillance System, we conducted secondary data analysis to compare PA between 31,078 cancer survivors with history of single-site <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> diagnosis at least 2 years prior to the survey, including <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> survivors of prostate [n = 2,951], female breast [n = 5,695], colon [n = 1,436], cervix [n = 2,211], endometrium [n = 1,080], and ovary [n = 732], and 235,351 non-<z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> participants between 40 and 79 years of age </plain></SENT>
<SENT sid="2" pm="."><plain>Self-reported PA and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> history data were collected through telephone interviews </plain></SENT>
<SENT sid="3" pm="."><plain>Weekly moderate- to vigorous-intensity PA levels were calculated in moderate-to-intensity physical activity equivalent (MIE) </plain></SENT>
<SENT sid="4" pm="."><plain>Least-squares means of MIE were obtained from sex, age groups (40-64 years [middle-aged] and 65-79 years [older]), and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> site-specific multivariable linear regression models, adjusting for age, age(2), race/ethnicity, household income, and education </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: <z:hpo ids='HP_0012125'>Prostate cancer</z:hpo> survivors reported participating in approximately 20 min/week more MIE, compared to their non-<z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> counterparts (P &lt; 0.10 for the middle-aged group; P &lt; 0.01 for the older group) </plain></SENT>
<SENT sid="6" pm="."><plain>Middle-aged cervical and <z:e sem="disease" ids="C0476089" disease_type="Neoplastic Process" abbrv="">endometrial cancer</z:e> survivors reported approximately 10 min/week less MIE (P &lt; 0.05 and P &lt; 0.15, respectively) </plain></SENT>
<SENT sid="7" pm="."><plain>Adjusted means of MIE were not different between <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> survivors of colon, female breast, or ovary and non-<z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> participants </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: This study demonstrates higher PA levels among <z:hpo ids='HP_0012125'>prostate cancer</z:hpo> survivors and lower PA levels among middle-aged cervical and <z:e sem="disease" ids="C0476089" disease_type="Neoplastic Process" abbrv="">endometrial cancer</z:e> survivors, compared to sex- and age group-matched general populations </plain></SENT>
</text></document>